Literature DB >> 26289228

Prioritizing Parental Worry Associated with Duchenne Muscular Dystrophy Using Best-Worst Scaling.

Holly Landrum Peay1,2, I L Hollin3, J F P Bridges3.   

Abstract

Duchenne muscular dystrophy (DMD) is a progressive, fatal pediatric disorder with significant burden on parents. Assessing disease impact can inform clinical interventions. Best-worst scaling (BWS) was used to elicit parental priorities among 16 short-term, DMD-related worries identified through community engagement. Respondents viewed 16 subsets of worries, identified using a balanced, incomplete block design, and identified the most and least worrying items. Priorities were assessed using best-worst scores (spanning +1 to -1) representing the relative number of times items were endorsed as most and least worrying. Independent-sample t-tests compared prioritization of parents with ambulatory and non-ambulatory children. Participants (n = 119) most prioritized worries about weakness progression (BW score = 0.64) and getting the right care over time (BW = 0.25). Compared to parents of non-ambulatory children, parents of ambulatory children more highly prioritized missing treatments (BW = 0.31 vs. 0.13, p < 0.001) and being a good enough parent (BW = 0.06 vs. -0.08, p = 0.010), and less prioritized child feeling like a burden (BW = -0.24 vs. -0.07, p < 0.001). Regardless of child's disease stage, caregiver interventions should address the emotional impact of caring for a child with a progressive, fatal disease. We demonstrate an accessible, clinically-relevant approach to prioritize disease impact using BWS, which offers an alternative to the use of traditional rating/ranking scales.

Entities:  

Keywords:  Best-worst scaling; Disease impact; Duchenne muscular dystrophy; Worry

Mesh:

Year:  2015        PMID: 26289228     DOI: 10.1007/s10897-015-9872-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  35 in total

1.  Using Best-Worst Scaling to Measure Caregiver Preferences for Managing their Child's ADHD: A Pilot Study.

Authors:  Susan dosReis; Xinyi Ng; Emily Frosch; Gloria Reeves; Charles Cunningham; John F P Bridges
Journal:  Patient       Date:  2015-10       Impact factor: 3.883

Review 2.  Valuing citizen and patient preferences in health: recent developments in three types of best-worst scaling.

Authors:  Terry N Flynn
Journal:  Expert Rev Pharmacoecon Outcomes Res       Date:  2010-06       Impact factor: 2.217

3.  The effects of warning smokers on perceived risk, worry, and motivation to quit.

Authors:  Renee E Magnan; Amber R Köblitz; Desiree J Zielke; Kevin D McCaul
Journal:  Ann Behav Med       Date:  2009-03-03

4.  Using the common sense model of self-regulation to understand the relationship between symptom reporting and trait negative affect.

Authors:  Lisa M McAndrew; Pablo A Mora; Karen S Quigley; Elaine A Leventhal; Howard Leventhal
Journal:  Int J Behav Med       Date:  2014-12

5.  The effect of caregiving on women in families with Duchenne/Becker muscular dystrophy.

Authors:  Aileen Kenneson; Janet Kay Bobo
Journal:  Health Soc Care Community       Date:  2010-06-16

6.  The importance of communication in collaborative decision making: facilitating shared mind and the management of uncertainty.

Authors:  Mary C Politi; Richard L Street
Journal:  J Eval Clin Pract       Date:  2010-09-12       Impact factor: 2.431

Review 7.  Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management.

Authors:  Katharine Bushby; Richard Finkel; David J Birnkrant; Laura E Case; Paula R Clemens; Linda Cripe; Ajay Kaul; Kathi Kinnett; Craig McDonald; Shree Pandya; James Poysky; Frederic Shapiro; Jean Tomezsko; Carolyn Constantin
Journal:  Lancet Neurol       Date:  2009-11-27       Impact factor: 44.182

8.  Patient reported outcome measures could help transform healthcare.

Authors:  Nick Black
Journal:  BMJ       Date:  2013-01-28

Review 9.  Duchenne and Becker muscular dystrophies.

Authors:  Kevin M Flanigan
Journal:  Neurol Clin       Date:  2014-08       Impact factor: 3.806

10.  Best--worst scaling: What it can do for health care research and how to do it.

Authors:  Terry N Flynn; Jordan J Louviere; Tim J Peters; Joanna Coast
Journal:  J Health Econ       Date:  2006-05-16       Impact factor: 3.883

View more
  14 in total

1.  Exploring variation in parental worries about HPV vaccination: a latent-class analysis.

Authors:  Melissa B Gilkey; Divya Mohan; Ellen M Janssen; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges
Journal:  Hum Vaccin Immunother       Date:  2019-05-07       Impact factor: 3.452

2.  Psychosocial Needs and Facilitators of Mothers Caring for Children with Duchenne/Becker Muscular Dystrophy.

Authors:  Holly L Peay; Bettina Meiser; Kathleen Kinnett; Aad Tibben
Journal:  J Genet Couns       Date:  2017-08-12       Impact factor: 2.537

3.  Parents' Views on the Best and Worst Reasons for Guideline-Consistent HPV Vaccination.

Authors:  Melissa B Gilkey; Mo Zhou; Annie-Laurie McRee; Melanie L Kornides; John F P Bridges
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-06-14       Impact factor: 4.254

4.  How Do Members of the Duchenne and Becker Muscular Dystrophy Community Perceive a Discrete-Choice Experiment Incorporating Uncertain Treatment Benefit? An Application of Research as an Event.

Authors:  John F P Bridges; Jui-Hua Tsai; Ellen Janssen; Norah L Crossnohere; Ryan Fischer; Holly Peay
Journal:  Patient       Date:  2019-04       Impact factor: 3.883

5.  Challenges to informed consent for exome sequencing: A best-worst scaling experiment.

Authors:  Rachel H Gore; John F P Bridges; Julie S Cohen; Barbara B Biesecker
Journal:  J Genet Couns       Date:  2019-09-25       Impact factor: 2.717

Review 6.  Using Best-Worst Scaling to Investigate Preferences in Health Care.

Authors:  Kei Long Cheung; Ben F M Wijnen; Ilene L Hollin; Ellen M Janssen; John F Bridges; Silvia M A A Evers; Mickael Hiligsmann
Journal:  Pharmacoeconomics       Date:  2016-12       Impact factor: 4.981

7.  Would You Use It With a Seal of Approval? Important Attributes of 2,4-Dinitrophenol (2,4-DNP) as a Hypothetical Pharmaceutical Product.

Authors:  Emma E Bleasdale; Sam N Thrower; Andrea Petróczi
Journal:  Front Psychiatry       Date:  2018-04-20       Impact factor: 4.157

8.  Developing and piloting an instrument to prioritize the worries of patients with acute myeloid leukemia.

Authors:  John Fp Bridges; Allison H Oakes; Crystal A Reinhart; Ernest Voyard; Bernadette O'Donoghue
Journal:  Patient Prefer Adherence       Date:  2018-04-27       Impact factor: 2.711

9.  Gene therapy as a potential therapeutic option for Duchenne muscular dystrophy: A qualitative preference study of patients and parents.

Authors:  Holly Landrum Peay; Ryan Fischer; Janice P Tzeng; Sharon E Hesterlee; Carl Morris; Amy Strong Martin; Colin Rensch; Edward Smith; Valeria Ricotti; Katherine Beaverson; Hannah Wand; Carol Mansfield
Journal:  PLoS One       Date:  2019-05-01       Impact factor: 3.240

10.  Experimental measurement of preferences in health and healthcare using best-worst scaling: an overview.

Authors:  Axel C Mühlbacher; Anika Kaczynski; Peter Zweifel; F Reed Johnson
Journal:  Health Econ Rev       Date:  2016-01-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.